FDA Approves Cuvposa for Chronic Drooling in Children
ROCKVILLE, Md., July 28, 2010--The U.S. Food and Drug Administration today approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling caused by neurologic disorders in children ages 3 years to 16 years. Drooling is normal...
Short URL: http://drugrehab.in/?p=71011
Posted by admin
on Jul 29 2010. Filed under New Drug Approvals.
You can follow any responses to this entry through the RSS 2.0.
Both comments and pings are currently closed.
